Athari, S. S. et al. Critical role of Toll-like receptors in pathophysiology of allergic asthma. Eur. J. Pharmacol. 808, 21–27 [2017].
Article CAS PubMed Google Scholar
Athari, S. S. Immune response shifting of asthma in aging. Middle-East J. Sci. Res. 13, 489–498 [2013].
CAS Google Scholar
Soriano, J. B. et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 5, 691–706 [2017].
Article Google Scholar
Boyman, O. et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 70, 727–754 [2015].
Article CAS PubMed Google Scholar
Brightling, C., Bradding, P., Pavord, I. & Wardlaw, A. New insights into the role of the mast cell in asthma. Clin. Exp. Allergy 33, 550–556 [2003].
Article CAS PubMed Google Scholar
Taghavi, M. et al. Role of pathogen-associated molecular patterns [PAMPS] in immune responses to fungal infections. Eur. J. Pharmacol. 808, 8–13 [2017].
Article CAS PubMed Google Scholar
Foster, P. S. et al. Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma. Immunological Rev. 278, 20–40 [2017].
Article CAS Google Scholar
Athari, S. S. & Athari, S. M. The importance of eosinophil, platelet and dendritic cell in asthma. Asian Pac. J. Trop. Dis. 4, S41–S47 [2014].
Article CAS Google Scholar
Galeone, C. et al. Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology? BioMed research international. 2018, 1–15 [2018].
Swedin, L. et al. Patient stratification and the unmet need in asthma. Pharmacol. Ther. 169, 13–34 [2017].
Article CAS PubMed Google Scholar
Stokes, J. R. & Casale, T. B. Characterization of asthma endotypes: implications for therapy. Ann. Allergy, Asthma Immunol. 117, 121–125 [2016].
Article CAS Google Scholar
Chung, K. F. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J. Intern. Med. 279, 192–204 [2016].
Article CAS PubMed Google Scholar
Lea, S. et al. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD. Eur. Respiratory J. 43, 409–420 [2014].
Article CAS Google Scholar
O'Byrne, P. M. et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respiratory Med. 4, 797–806 [2016].
Article CAS Google Scholar
Svenningsen, S. & Nair, P. Asthma endotypes and an overview of targeted therapy for asthma. Front. Med. 4, 158 [2017].
Article Google Scholar
Nair, P. et al. Safety and efficacy of a CXCR 2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial. Clin. Exp. Allergy 42, 1097–1103 [2012].
Article CAS PubMed Google Scholar
Hsieh, Y.-Y. et al. JAK-1 rs2780895 C-related genotype and allele but not JAK-1 rs10789166, rs4916008, rs2780885, rs17127114, and rs3806277 are associated with higher susceptibility to asthma. Genet. Test. Mol. Biomark. 15, 841–847 [2011].
Article CAS Google Scholar
Howell, M. D., Fitzsimons, C. & Smith, P. A. JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease. Ann Allerg Asthma Immunol. 120, 367–375 [2018].
Article CAS Google Scholar
Wurster, A. L., Tanaka, T. & Grusby, M. J. The biology of Stat4 and Stat6. Oncogene 19, 2577 [2000].
Article CAS PubMed Google Scholar
Rudolph, A.-K., Walter, T. & Erkel, G. The fungal metabolite cyclonerodiol inhibits IL-4/IL-13 induced Stat6-signaling through blocking the association of Stat6 with p38, ERK1/2 and p300. Int. Immunopharmacol. 65, 392–401 [2018].
Article CAS PubMed Google Scholar
McCormick, S. M. & Heller, N. M. Commentary: IL-4 and IL-13 receptors and signaling. Cytokine 75, 38–50 [2015].
Article CAS PubMed PubMed Central Google Scholar
Walford, H. H. & Doherty, T. A. STAT6 and lung inflammation. Jak.Stat. 2, e25301 [2013].
Article PubMed PubMed Central Google Scholar
Lambrecht, B. N. & Hammad, H. The immunology of asthma. Nat. Immunol. 16, 45 [2015].
Article CAS PubMed Google Scholar
Makinde, T., Murphy, R. F. & Agrawal, D. K. The regulatory role of TGF‐β in airway remodeling in asthma. Immunol. cell Biol. 85, 348–356 [2007].
Article CAS PubMed Google Scholar
Wen, F.-Q. et al. Interleukin-4–and interleukin-13–enhanced transforming growth factor-β 2 production in cultured human bronchial epithelial cells is attenuated by interferon-γ. Am. J. Respir. Cell Mol. Biol. 26, 484–490 [2002].
Article CAS PubMed Google Scholar
Zhuang, S. Regulation of STAT signaling by acetylation. Cell. Signal. 25, 1924–1931 [2013].
Article CAS PubMed PubMed Central Google Scholar
Schindler, C., Levy, D. E. & Decker, T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059–20063 [2007].
Article CAS PubMed Google Scholar
So, E.-Y. et al. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells. Mol. Immunol. 44, 3416–3426 [2007].
Article CAS PubMed Google Scholar
Wang, Y., Malabarba, M. G., Nagy, Z. S. & Kirken, R. A. Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6 roles for multiple phosphorylation sites and Stat6 function. J. Biol. Chem. 279, 25196–25203 [2004].
Article CAS PubMed Google Scholar
Yeganeh, B. et al. Emerging mediators of airway smooth muscle dysfunction in asthma. Pulm. Pharmacol. Ther. 26, 105–111 [2013].
Article CAS PubMed Google Scholar
Ip, W., Wong, C. & Lam, C. Interleukin [IL]‐4 and IL‐13 up‐regulate monocyte chemoattractant protein‐1 expression in human bronchial epithelial cells: involvement of p38 mitogen‐activated protein kinase, extracellular signal‐regulated kinase 1/2 and Janus kinase‐2 but not c‐Jun NH2‐terminal kinase 1/2 signalling pathways. Clin. Exp. Immunol. 145, 162–172 [2006].
Article CAS PubMed PubMed Central Google Scholar
Pope, S. M. et al. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J. Immunol. 175, 5341–5350 [2005].
Article CAS PubMed Google Scholar
Schwartz, D. M. et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat. Rev. Drug Discov. 16, 843 [2017].
Article CAS PubMed Google Scholar
Morlacchi, P., Mandal, P. K. & McMurray, J. S. Synthesis and in vitro evaluation of a peptidomimetic inhibitor targeting the Src homology 2 [SH2] domain of STAT6. ACS medicinal Chem. Lett. 5, 69–72 [2013].
Article CAS Google Scholar
Mandal, P. K. et al. Targeting the Src homology 2 [SH2] domain of signal transducer and activator of transcription 6 [STAT6] with cell-permeable, phosphatase-stable phosphopeptide mimics potently inhibits Tyr641 phosphorylation and transcriptional activity. J. Med. Chem. 58, 8970–8984 [2015].
Article CAS PubMed PubMed Central Google Scholar
Miklossy, G., Hilliard, T. S. & Turkson, J. Therapeutic modulators of STAT signalling for human diseases. Nat. Rev. Drug Discov. 12, 611 [2013].
Article CAS PubMed PubMed Central Google Scholar
Lugogo, N. L., Bappanad, D. & Kraft, M. Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim. Biophys. Acta 1810, 1120–1126 [2011].
Article CAS PubMed PubMed Central Google Scholar
André, D. M. et al. Therapy with resveratrol attenuates obesity-associated allergic airway inflammation in mice. Int. Immunopharmacol. 38, 298–305 [2016].
Article CAS PubMed Google Scholar
Tilg, H. & Moschen, A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772 [2006].
Article CAS PubMed Google Scholar
Shore, S. A. et al. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 118, 389–395 [2006].
Article CAS PubMed Google Scholar
Miller, M. et al. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J. Immunol. 182, 684–691 [2009].
Article CAS PubMed Google Scholar
Williams, A. S. et al. Role of the adiponectin binding protein, T-cadherin [Cdh23], in allergic airways responses in mice. PloS ONE 7, e41088 [2012].
Article CAS PubMed PubMed Central Google Scholar
Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251 [2012].
Article CAS PubMed PubMed Central Google Scholar
Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332 [2007].
Article CAS PubMed Google Scholar
Sag, D., Carling, D., Stout, R. D. & Suttles, J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633–8641 [2008].
Article CAS PubMed Google Scholar
Gilmore, T. D. Introduction to NF-κB: players, pathways, perspectives. Oncogene 25, 6680 [2006].
Article CAS PubMed Google Scholar
Mishra, V., Banga, J. & Silveyra, P. Oxidative stress and cellular pathways of asthma and inflammation: therapeutic strategies and pharmacological targets. Pharmacol. Ther. 181, 169–182 [2018].
Article CAS PubMed Google Scholar
Zhu, L. et al. Adiponectin alleviates exacerbation of airway inflammation and oxidative stress in obesity-related asthma mice partly through AMPK signaling pathway. Int. Immunopharmacol. 67, 396–407 [2019].
Article CAS PubMed Google Scholar
Catz, S. D. & Johnson, J. L. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 20, 7342 [2001].
Article CAS PubMed Google Scholar
Viatour, P. et al. NF-κB2/p100 induces Bcl-2 expression. Leukemia 17, 1349 [2003].
Article CAS PubMed Google Scholar
Akita, K., Kawata, S. & Shimotohno, K. p21WAF1 modulates NF-κB signaling and induces anti-apoptotic protein Bcl-2 in Tax-expressing rat fibroblast. Virology 332, 249–257 [2005].
Article CAS PubMed Google Scholar
Ajuwon, K. M. & Spurlock, M. E. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am. J. Physiol.Regul. Integr. Comp. Physiol. 288, R1220–R1225 [2005].
Article CAS PubMed Google Scholar
Ouchi, N. et al. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 14, 561–566 [2003].
Article CAS PubMed Google Scholar
Lovren, F. et al. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am. J. Physiol. Heart Circ. Physiol. 299, H656–H663 [2010].
Article CAS PubMed PubMed Central Google Scholar
Masaki, T. et al. Adiponectin protects LPS‐induced liver injury through modulation of TNF‐α in KK‐Ay obese mice. Hepatology 40, 177–184 [2004].
Article CAS PubMed Google Scholar
Ouchi, N. et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102, 1296–1301 [2000].
Article CAS PubMed Google Scholar
Xue, L. et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J. Allergy Clin. Immunol. 133, 1184–1194 [2014]. e1187.
Article CAS PubMed PubMed Central Google Scholar
Domingo, C. et al. The prostaglandin D 2 receptor 2 pathway in asthma: a key player in airway inflammation. Respir. Res. 19, 189 [2018].
Article CAS PubMed PubMed Central Google Scholar
Matsuda, K. et al. Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J. Allergy Clin. Immunol. 116, 1357–1363 [2005].
Article CAS PubMed Google Scholar
Townley, R. G. & Agrawal, S. CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils. Ann. Allerg. Asthma Immunol. 109, 365–374 [2012].
Article CAS Google Scholar
Nagata, K. et al. CRTH2, an orphan receptor of T‐helper‐2‐cells, is expressed on basophils and eosinophils and responds to mast cell‐derived factor [s]. FEBS Lett. 459, 195–199 [1999].
Article CAS PubMed Google Scholar
Pettipher, R. The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responses. Br. J. Pharmacol. 153, S191–S199 [2008].
Article CAS PubMed Google Scholar
Coleman, R. & Sheldrick, R. Prostanoid‐induced contraction of human bronchial smooth muscle is mediated by TP‐receptors. Br. J. Pharmacol. 96, 688–692 [1989].
Article CAS PubMed PubMed Central Google Scholar
Kupczyk, M. & Kuna, P. Targeting the PGD 2/CRTH2/DP1 signaling pathway in asthma and allergic disease: current status and future perspectives. Drugs 77, 1281–1294 [2017].
Article CAS PubMed PubMed Central Google Scholar
Sykes, D. A. et al. Fevipiprant [QAW039], a slowly dissociating CRTh2 antagonist with the potential for improved clinical efficacy. Mol. Pharmacol. 89, 593–605 [2016].
Article CAS PubMed Google Scholar
Xue, L. et al. in C35. ASTHMA AND ALLERGY CELLULAR INVESTIGATIONS A5301-A5301 [American Thoracic Society, 2017].
Gazi, L. et al. Δ12-Prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat. 75, 153–167 [2005].
Article CAS PubMed Google Scholar
Sawyer, N. et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br. J. Pharmacol. 137, 1163–1172 [2002].
Article CAS PubMed PubMed Central Google Scholar
Sandham, D. A. et al. Discovery of fevipiprant [NVP-QAW039], a potent and selective DP2 receptor antagonist for treatment of asthma. ACS Med. Chem. Lett. 8, 582–586 [2017].
Article CAS PubMed PubMed Central Google Scholar
Xue, L. et al. Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2. J. Immunol. 188, 694–702 [2012].
Article CAS PubMed Google Scholar
Gervais, F. G. et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108, 982–988 [2001].
Article CAS PubMed Google Scholar
Xue, L. et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J. Immunol. 175, 6531–6536 [2005].
Article CAS PubMed Google Scholar
Patel, K. D. Eosinophil tethering to interleukin-4–activated endothelial cells requires both P-selectin and vascular cell adhesion molecule-1. Blood 92, 3904–3911 [1998].
Article CAS PubMed Google Scholar
Moore, P. E. et al. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol.Lung Cell. Mol. Physiol. 282, L847–L853 [2002].
Article CAS PubMed Google Scholar
Farne, H., Jackson, D. J. & Johnston, S. L. Are emerging PGD2 antagonists a promising therapy class for treating asthma? Expert Opin. Emerg. Drugs 21, 359–364 [2016].
Aceves, S. S. & Ackerman, S. J. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol. allergy Clin. North Am. 29, 197–211 [2009].
Article PubMed PubMed Central Google Scholar
Molfino, N. et al. Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptor. Clin. Exp. Allergy 42, 712–737 [2012].
Article CAS PubMed Google Scholar
Wood, B. L. et al. The effects of caregiver depression on childhood asthma: pathways and mechanisms. Ann. Allergy, Asthma Immunol. 121, 421–427 [2018].
Article Google Scholar
Zaitsu, M. et al. Direct evidence that LTC4 and LTB4 but not TXA2 are involved in asthma attacks in children. J. Asthma 35, 445–448 [1998].
Article CAS PubMed Google Scholar
Gelfand, E. W. Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma. Semin. Immunol 33, 44–51 [2017].
Article CAS PubMed PubMed Central Google Scholar
Sampson, A., Castling, D., Green, C. & Price, J. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch. Dis. Child. 73, 221–225 [1995].
Article CAS PubMed PubMed Central Google Scholar
Montuschi, P. & Barnes, P. J. Exhaled leukotrienes and prostaglandins in asthma. J. Allergy Clin. Immunol. 109, 615–620 [2002].
Article CAS PubMed Google Scholar
Sheller, J. R. et al. Nuclear factor kappa B induction in airway epithelium increases lung inflammation in allergen-challenged mice. Exp. Lung Res. 35, 883–895 [2009].
Article CAS PubMed PubMed Central Google Scholar
Schuliga, M. NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules 5, 1266–1283 [2015].
Article CAS PubMed PubMed Central Google Scholar
Chen, G. G. et al. Increased inducible nitric oxide synthase in lung carcinoma of smokers. Cancer. 112, 372–381 [2008].
Article CAS PubMed Google Scholar
Anto, R. J. et al. Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: correlation with induction of cyclooxygenase-2. Carcinogenesis 23, 1511–1518 [2002].
Article CAS PubMed Google Scholar
Kim, J.-B. et al. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-κB inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30, 2345–2351 [2007].
Article CAS PubMed Google Scholar
Shin, N.-R. et al. Galgeun-tang attenuates cigarette smoke and lipopolysaccharide induced pulmonary inflammation via IκBα/NF-κB signaling. Molecules 23, 2489 [2018].
Article CAS PubMed Central Google Scholar
Contoli, M. et al. Role of deficient type III interferon-λ production in asthma exacerbations. Nat. Med. 12, 1023 [2006].
Article CAS PubMed Google Scholar
Edwards, M. et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol. 6, 797 [2013].
Article CAS PubMed Google Scholar
Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101 [2006].
Article CAS PubMed Google Scholar
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640–643 [2003].
Article CAS PubMed Google Scholar
Zhu, J. et al. Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 143, 114–125 [2019]. e114.
Article CAS PubMed PubMed Central Google Scholar
Sharma, R. & Chopra, V. Effect of the Wingless [wg1] mutation on wing and haltere development in Drosophila melanogaster. Dev. Biol. 48, 461–465 [1976].
Article CAS PubMed Google Scholar
Yurt, M. et al. Vitamin D supplementation blocks pulmonary structural and functional changes in a rat model of perinatal vitamin D deficiency. Am. J. Physiol. Lung Cell. Mol. Physiol. 307, L859–L867 [2014].
Article CAS PubMed PubMed Central Google Scholar
Baarsma, H. A., Königshoff, M. & Gosens, R. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets. Pharmacol. Ther. 138, 66–83 [2013].
Article CAS PubMed Google Scholar
Hussain, M. et al. Wnt/β-catenin signaling links embryonic lung development and asthmatic airway remodeling. Biochim. Biophys. Acta 1863, 3226–3242 [2017].
Article CAS Google Scholar
Huo, Y. et al. Tiotropium inhibits methacholine-induced extracellular matrix production via β-catenin signaling in human airway smooth muscle cells. Int. J. Chronic Obstr. Pulm. Dis. 13, 1469 [2018].
Article CAS Google Scholar
Jia, X. X., Zheng, Y. R. & Huang, Y. Effects of Wnt/β-catenin signal pathway on asthma airway remodeling. Chinese. J. Pathophysiol. 33, 1683–1689 [2017].
Google Scholar
Royer, J. et al. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. Eur. J. Clin. Investig. 38, 663–671 [2008].
Article CAS Google Scholar
Vatrella, A. et al. Dupilumab: a novel treatment for asthma. J. Asthma Allerg. 7, 123 [2014].
Article CAS Google Scholar
Kuna, P., Bjermer, L. & Tornling, G. Two phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma. Drug Des. Dev. Ther. 10, 2759 [2016].
Article CAS Google Scholar
Tromp, I. I. et al. 25-Hydroxyvitamin D concentrations, asthma and eczema in childhood: the generation R study. Clin. Nutr. 37, 169–176 [2018].
Article CAS PubMed Google Scholar
Brehm, J. M. et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 126, 52–58 [2010]. e55.
Article CAS PubMed PubMed Central Google Scholar
Sypniewska, G. et al. 25-Hydroxyvitamin D, biomarkers of eosinophilic inflammation, and airway remodeling in children with newly diagnosed untreated asthma. Allergy Asthma Proceedings 38, 29–36 [2017].
Pálmer, H. G. et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154, 369–388 [2001].
Article PubMed PubMed Central Google Scholar
Aguilera, O. et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1α, 25-dihydroxyvitamin D 3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28, 1877–1884 [2007].
Article CAS PubMed Google Scholar
Huang, Y. et al. Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway. Int. Immunopharmacol. 68, 88–94 [2019].
Article CAS PubMed Google Scholar
Solberg, O. D. et al. Airway epithelial miRNA expression is altered in asthma. Am. J. Respir. Crit. Care Med. 186, 965–974 [2012].
Article CAS PubMed PubMed Central Google Scholar
Pua, H. H. & Ansel, K. M. MicroRNA regulation of allergic inflammation and asthma. Curr. Opin. Immunol. 36, 101–108 [2015].
Article CAS PubMed PubMed Central Google Scholar
Aich, J. et al. Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase [INPP4A]. Int. Immunopharmacol. 14, 438–443 [2012].
Article CAS PubMed Google Scholar
Xia, H., Li, Y. & Lv, X. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Int. J. Oncol. 49, 1325–1333 [2016].
Article CAS PubMed PubMed Central Google Scholar
Lin, Y.-J. et al. Tumor hypoxia regulates forkhead box C1 to promote lung cancer progression. Theranostics 7, 1177 [2017].
Article CAS PubMed PubMed Central Google Scholar
Zhang, H., Hu, J. & Liu, L. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs. Biomed. Pharmacother. 95, 215–222 [2017].
Article CAS PubMed Google Scholar
Zhu, X. et al. FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer. Am. J. Cancer Res. 7, 1642 [2017].
CAS PubMed PubMed Central Google Scholar
Lin, Z. et al. miR‐639 regulates transforming growth factor beta‐induced epithelial–mesenchymal transition in human tongue cancer cells by targeting FOXC 1. Cancer Sci. 105, 1288–1298 [2014].
Article CAS PubMed PubMed Central Google Scholar
Liu, Y. et al. MicroRNA-200a affects the proliferation of airway smooth muscle cells and airway remodeling by targeting FOXC1 via the PI3K/AKT signaling pathway in ovalbumin-induced asthmatic mice. Cell. Physiol. Biochem. 50, 2365–2389 [2018].
Article CAS PubMed Google Scholar
Huang, L. et al. FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway. Am. J. Transl. Res. 9, 1297 [2017].
CAS PubMed PubMed Central Google Scholar
Feng, X.-J. et al. The PTEN/PI3K/Akt signaling pathway mediates HMGB1-induced cell proliferation by regulating the NF-κB/cyclin D1 pathway in mouse mesangial cells. Am. J. Physiol. Cell Physiol. 306, C1119–C1128 [2014].
Article CAS PubMed Google Scholar
Li, C. et al. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+-induced neuronal death in cultured hippocampal neurons. Toxicol. Appl. Pharmacol. 229, 351–361 [2008].
Article CAS PubMed Google Scholar
Sun, Y., Luo, D. & Liao, D. J. CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells. J. Carcinog. 11, 12 [2012].
Gao, N. et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am. J. Physiol.Cell Physiol. 287, C281–C291 [2004].
Article CAS PubMed Google Scholar
Wu, H. et al. A negative feedback loop between miR‐200b and the nuclear factor‐κB pathway via IKBKB/IKK‐β in breast cancer cells. FEBS J. 283, 2259–2271 [2016].
Article CAS PubMed Google Scholar
Bera, A. et al. NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell. Signal. 25, 2575–2586 [2013].
Article CAS PubMed PubMed Central Google Scholar
Chagani, T. et al. Fas [CD95] and FasL [CD95L] expression in airway epithelium of subjects with fatal and non-fatal asthma. Am. J. Respir. Crit. Care Med. 163, A739 [2001].
Google Scholar
Rahimi, R. A. & Leof, E. B. TGF‐β signaling: a tale of two responses. J. Cell. Biochem. 102, 593–608 [2007].
Article CAS PubMed Google Scholar
Pittet, J.-F. et al. TGF-β is a critical mediator of acute lung injury. J. Clin. Investig. 107, 1537–1544 [2001].
Article CAS PubMed PubMed Central Google Scholar
Miller, M. et al. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L162–L169 [2006].
Article CAS PubMed Google Scholar
Cohn, L., Elias, J. A. & Chupp, G. L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789–815 [2004].
Article CAS PubMed Google Scholar
Kaur, M., Kaur, T., Kamboj, S. S. & Singh, J. Roles of galectin-7 in cancer. Asian Pac. J. Cancer Prev. 17, 455–461 [2016].
Article PubMed Google Scholar
Yin, G. et al. Galectin-7 is associated with bronchial epithelial cell apoptosis in asthmatic children. Zhonghua er ke za zhi Chin. J. Pediatrics 44, 523–526 [2006].
Google Scholar
Kuwabara, I. et al. Galectin-7 [PIG1] exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome cRelease. J. Biol. Chem. 277, 3487–3497 [2002].
Article CAS PubMed Google Scholar
Vizetto-Duarte, C. et al. Isololiolide, a carotenoid metabolite isolated from the brown alga Cystoseira tamariscifolia, is cytotoxic and able to induce apoptosis in hepatocarcinoma cells through caspase-3 activation, decreased Bcl-2 levels, increased p53 expression and PARP cleavage. Phytomedicine 23, 550–557 [2016].
Article CAS PubMed Google Scholar
Villeneuve, C. et al. Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells. Mol. Biol. Cell 22, 999–1013 [2011].
Article CAS PubMed PubMed Central Google Scholar
Sun, X. & Zhang, W. Silencing of Gal-7 inhibits TGF-β1-induced apoptosis of human airway epithelial cells through JNK signaling pathway. Exp. Cell Res. 375, 100–105 [2019].
Article CAS PubMed Google Scholar
Liu, J., Minemoto, Y. & Lin, A. c-Jun N-terminal protein kinase 1 [JNK1], but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol. Cell. Biol. 24, 10844–10856 [2004].
Article CAS PubMed PubMed Central Google Scholar
Li, C. et al. Role of c-Jun N-terminal kinase signal transduction pathway in the course of airway remodeling of asthma rat. Zhonghua er ke za zhi Chin. J. Pediatrics. 46, 535–539 [2008].
Google Scholar
Han, T. et al. Enhanced expressions of Wnt5a/JNK signaling pathway-related molecules in the lung tissues of asthmatic rats. Xi bao yu fen. zi mian yi xue za zhi Chin. J. Cell. Mol. Immunol. 31, 325–327 [2015]. 332.
CAS Google Scholar
De Wever, O. et al. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-β or wounding. J. cell Sci. 117, 4691–4703 [2004].
Article CAS PubMed Google Scholar
Di Rosanna, P. & Salvatore, C. Reactive oxygen species, inflammation, and lung diseases. Curr. Pharm. Des. 18, 3889–3900 [2012].
Article PubMed Google Scholar
Park, S. J. et al. L-2-Oxothiazolidine-4-carboxylic acid or α-lipoic acid attenuates airway remodeling: involvement of nuclear factor-κB [NF-κB], nuclear factor erythroid 2p45-related factor-2 [Nrf2], and hypoxia-inducible factor [HIF]. Int. J. Mol. Sci. 13, 7915–7937 [2012].
Article CAS PubMed PubMed Central Google Scholar
Zeng, H. et al. Polydatin attenuates reactive oxygen species-induced airway remodeling by promoting Nrf2-mediated antioxidant signaling in asthma mouse model. Life Sci. 218, 25–30 [2019].
Article CAS PubMed Google Scholar
Huang, K. et al. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells. Mol. Cell. Endocrinol. 399, 178–189 [2015].
Article CAS PubMed Google Scholar
Lachapelle, P., Li, M., Douglass, J. & Stewart, A. Safer approaches to therapeutic modulation of TGF-β signaling for respiratory disease. Pharmacol. Ther. 187, 98–113 [2018].
Article CAS PubMed Google Scholar
Zissler, U. et al. Current and future biomarkers in allergic asthma. Allergy 71, 475–494 [2016].
Article CAS PubMed Google Scholar
Ding, F., Fu, Z. & Liu, B. Lipopolysaccharide exposure alleviates asthma in mice by regulating Th2/Th2 and Treg/Th27 balance. Med. Sci. Monit. 24, 3220 [2018].
Article CAS PubMed PubMed Central Google Scholar
Liang, P. et al. Huai Qi Huang corrects the balance of Th2/Th2 and Treg/Th27 in an ovalbumin-induced asthma mouse model. Biosci. Rep. 37, BSR20171071 [2017].
Article CAS PubMed PubMed Central Google Scholar
Na, H. et al. Concomitant suppression of TH2 and TH17 cell responses in allergic asthma by targeting retinoic acid receptor–related orphan receptor γt. J. Allergy Clin. Immunol. 141, 2061–2073 [2018].
Chen, T. et al. The imbalance of FOXP3/GATA3 in egulatory T cells from the peripheral blood of asthmatic patients. J. Immunol. Res. 2018, 1–10 [2018].
Zhu, Y. et al. Analysis of lncRNA expression in patients with eosinophilic and neutrophilic asthma focusing on LNC_000127. Front. Genet. 10, 141 [2019].
Article CAS PubMed PubMed Central Google Scholar
Zhang, X.-y et al. GAS5 promotes airway smooth muscle cell proliferation in asthma via controlling miR-10a/BDNF signaling pathway. Life Sci. 212, 93–101 [2018].
Article CAS PubMed Google Scholar
Zhu, Y.-J., Mao, D., Gao, W. & Hu, H. Peripheral whole blood lncRNA expression analysis in patients with eosinophilic asthma. Medicine 97, e9817 [2018].
Narożna, B., Langwiński, W. & Szczepankiewicz, A. Non-coding RNAs in pediatric airway diseases. Genes 8, 348 [2017].
Article CAS PubMed Central Google Scholar
Qiu, Y.-y et al. LncRNA-MEG3 functions as a competing endogenous RNA to regulate Treg/Th27 balance in patients with asthma by targeting microRNA-17/RORγt. Biomed. Pharmacother. 111, 386–394 [2019].
Article CAS PubMed Google Scholar
Paplińska, M. et al. Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients. Cytokine 60, 393–399 [2012].
Article CAS PubMed Google Scholar
Shieh, Y.-H. et al. Zerumbone enhances the Th2 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice. Int. Immunopharmacol. 24, 383–391 [2015].
Article CAS PubMed Google Scholar
Gui-min, G. The progress of eotaxin and the association with ashtma. Int J. Immunol. 2, 93–96 [2006].
Yuan, F. et al. JAX2, an ethanol extract of Hyssopus cuspidatus Boriss, can prevent bronchial asthma by inhibiting MAPK/NF-κB inflammatory signaling. Phytomedicine 57, 305–314 [2019].
Article CAS PubMed Google Scholar
Henderson, W. R. Jr et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165, 108–116 [2002].
Article PubMed Google Scholar
Dahlen, S.-E. Pharmacological characterization of leukotriene receptors. Am. J. Respir. Crit. Care Med. 161, S41–S45 [2000].
Article CAS PubMed Google Scholar
Gauvreau, G. M., Parameswaran, K. N., Watson, R. M. & O'BYRNE, P. M. Inhaled leukotriene E4, but not leukotriene D4, increased airway inflammatory cells in subjects with atopic asthma. Am. J. Respir. Crit. Care Med. 164, 1495–1500 [2001].
Article CAS PubMed Google Scholar
Suh, D. H. et al. P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma. J. Cell. Mol. Med. 20, 333–341 [2016].
Article CAS PubMed Google Scholar
Kanaoka, Y. & Boyce, J. A. Cysteinyl leukotrienes and their receptors; emerging concepts. Allerg. Asthma Immunol. Res. 6, 288–295 [2014].
Article CAS Google Scholar
Kanaoka, Y., Maekawa, A. & Austen, K. F. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. J. Biol. Chem. 288, 10967–10972 [2013].
Article CAS PubMed PubMed Central Google Scholar
Trinh, H. K. T. et al. Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma. Prostaglandins, Leukotrienes Essent. Fat. Acids 141, 17–23 [2019].
Article CAS Google Scholar
Paruchuri, S. et al. Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor. J. Exp. Med. 206, 2543–2555 [2009].
Article CAS PubMed PubMed Central Google Scholar
Raker, V. K., Becker, C. & Steinbrink, K. The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases. Front. Immunol. 7, 123 [2016].
Article CAS PubMed PubMed Central Google Scholar
Ahmad, F. et al. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets. Oral. Dis. 21, e25–e50 [2015].
Article CAS PubMed Google Scholar
Bateman, E. D., Goehring, U.-M., Richard, F. & Watz, H. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma. J. Allergy Clin. Immunol. 138, 142–149 [2016].
Southworth, T. et al. Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients. Cytokine 113, 68–73 [2019].
Article CAS PubMed Google Scholar
Woodruff, P. G. et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl Acad. Sci. 104, 15858–15863 [2007].
Article PubMed PubMed Central Google Scholar
Grundy, S. et al. Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells. Respiratory Res. 17, 9 [2016].
Article CAS Google Scholar
Goleva, E. et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am. J. Respi. Crit. Care Med. 188, 1193–1201 [2013].
Article CAS Google Scholar
Bjørgo, E. & Taskén, K. Novel mechanism of signaling by CD28. Immunol. Lett. 129, 1–6 [2010].
Article CAS PubMed Google Scholar
Barnes, P. J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 131, 636–645 [2013].
Article CAS PubMed Google Scholar
Matera, M. G., Page, C. & Rinaldi, B. β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseases. Curr. Opin. Pharmacol. 40, 142–146 [2018].
Article CAS PubMed Google Scholar
Johnson, M. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation. J. Allergy Clin. Immunol. 117, 18–24 [2006].
Article CAS PubMed Google Scholar
Krug, N. et al. Enhanced expression of fas ligand [CD95L] on T cells after segmental allergen provocation in asthma. J. Allergy Clin. Immunol. 103, 649–655 [1999].
Article CAS PubMed Google Scholar
Müller, M. et al. Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects. Eur. Respir. J. 28, 513–522 [2006].
Article PubMed Google Scholar
Druilhe, A. et al. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am. J. Respir. C ell Mol. Biol. 19, 747–757 [1998].
Article CAS Google Scholar
Le Gallo, M., Poissonnier, A., Blanco, P. & Legembre, P. CD95/Fas, non-apoptotic signaling pathways, and kinases. Front. Immunol. 8, 1216 [2017].
Article CAS PubMed PubMed Central Google Scholar
Peter, M. E. et al. The role of CD95 and CD95 ligand in cancer. Cell Death Differ. 22, 549 [2015].
Article CAS PubMed PubMed Central Google Scholar
Krammer, P. H., Arnold, R. & Lavrik, I. N. Life and death in peripheral T cells. Nat. Rev. Immunol. 7, 532 [2007].
Article CAS PubMed Google Scholar
Park, S.-M., Schickel, R. & Peter, M. E. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr. Opin. Cell Biol. 17, 610–616 [2005].
Article CAS PubMed Google Scholar
Desbarats, J. et al. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118 [2003].
Article CAS PubMed Google Scholar
Neumann, L. et al. Dynamics within the CD95 death‐inducing signaling complex decide life and death of cells. Mol. Syst. Biol. 6 [2010].
Kleber, S. et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13, 235–248 [2008].
Article CAS PubMed Google Scholar
Wisniewski, P., Ellert-Miklaszewska, A., Kwiatkowska, A. & Kaminska, B. Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFκB-TIMP-2 pathway. Cell Signal. 22, 212–220 [2010].
Article CAS PubMed Google Scholar
Fang, Y. et al. Comparison of sensitivity of Th2, Th2, and Th27 cells to Fas‐mediated apoptosis. J. Leukoc. Biol. 87, 1019–1028 [2010].
Article CAS PubMed PubMed Central Google Scholar
Williams, J. W. et al. Non-apoptotic Fas [CD95] signaling on T cells regulates the resolution of Th2-mediated inflammation. Front. Immunol. 9, 2521 [2018].
Article CAS PubMed PubMed Central Google Scholar
Liu, Y. et al. Protective effect of electro-acupuncture at maternal different points on perinatal nicotine exposure-induced pulmonary dysplasia in offspring based on HPA axis and signal transduction pathway. Biochem. B iophys. Res. Commun. 505, 586–592 [2018].
Article CAS Google Scholar
Rehan, V. K. & Torday, J. S. PPARγ signaling mediates the evolution, development, homeostasis, and repair of the lung. PPAR Res. 2012 [2012].
Rijken, D. & Sakharov, D. Basic principles in thrombolysis: regulatory role of plasminogen. Thrombosis Res. 103, S41–S49 [2001].
Article CAS Google Scholar
Cho, S. H., Ryu, C. H. & Oh, C. K. Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp. Biol. Med. 229, 138–146 [2004].
Article CAS Google Scholar
Lee, S. H. et al. A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma. Am. J. Respir. C ell Mol. Biol. 46, 842–846 [2012].
Article CAS Google Scholar
Miyamoto, S. et al. Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L908–L916 [2011].
Article CAS PubMed Google Scholar
Denzel, A. et al. Basophils enhance immunological memory responses. Nat. Immunol. 9, 733 [2008].
Article CAS PubMed Google Scholar
Mukai, K., Obata, K., Tsujimura, Y. & Karasuyama, H. New insights into the roles for basophils in acute and chronic allergy. Allergol. Int. 58, 11–19 [2009].
Article CAS PubMed Google Scholar
Prussin, C. & Metcalfe, D. D. 4. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 111, S486–S494 [2003].
Article CAS PubMed Google Scholar
Sokol, C. L., Barton, G. M., Farr, A. G. & Medzhitov, R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 9, 310 [2008].
Article CAS PubMed PubMed Central Google Scholar
Liu, Y. et al. An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response. J. Exp. Med. 204, 93–103 [2007].
Article CAS PubMed PubMed Central Google Scholar
Zhu, M. et al. Positive and negative regulation of FcεRI-mediated signaling by the adaptor protein LAB/NTAL. J. Exp. Med. 200, 991–1000 [2004].
Article CAS PubMed PubMed Central Google Scholar
Zhu, M., Rhee, I., Liu, Y. & Zhang, W. Negative regulation of FcϵRI-mediated signaling and mast cell function by the adaptor protein LAX. J. Biol. Chem. 281, 18408–18413 [2006].
Article CAS PubMed Google Scholar
Kinet, J.-P. The high-affinity IgE receptor [FcεRI]: from physiology to pathology. Annu. Rev. Immunol. 17, 931–972 [1999].
Article CAS PubMed Google Scholar
Gilfillan, A. M. & Tkaczyk, C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6, 218 [2006].
Article CAS PubMed Google Scholar
Li, P. et al. BATF–JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543 [2012].
Article CAS PubMed PubMed Central Google Scholar
Lu, Y. et al. The natural compound nujiangexanthone A suppresses mast cell activation and allergic asthma. Biochem. Pharmacol. 100, 61–72 [2016].
Article CAS PubMed Google Scholar
Kitaura, J. et al. Regulation of highly cytokinergic IgE-induced mast cell adhesion by Src, Syk, Tec, and protein kinase C family kinases. J. Immunol. 174, 4495–4504 [2005].
Article CAS PubMed Google Scholar
Weinblatt, M. E. et al. An oral spleen tyrosine kinase [Syk] inhibitor for rheumatoid arthritis. New Engl. J. Med. 363, 1303–1312 [2010].
Article CAS PubMed Google Scholar
Zhang, W. et al. Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway. Exp. C ell Res. 376, 124–132 [2019].
Article CAS Google Scholar
Aggarwal, N. R., King, L. S. & D'Alessio, F. R. Diverse macrophage populations mediate acute lung inflammation and resolution. Am. J. Physiol.Lung Cell. Mol. Physiol. 306, L709–L725 [2014].
Article CAS PubMed PubMed Central Google Scholar
Liu, G. & Yang, H. Modulation of macrophage activation and programming in immunity. J. Cell. Physiol. 228, 502–512 [2013].
Article CAS PubMed Google Scholar
Tang, L. et al. M2A and M2C macrophage subsets ameliorate inflammation and fibroproliferation in acute lung injury through interleukin 10 pathway. Shock 48, 119–129 [2017].
Article CAS PubMed Google Scholar
Han, G., Chen, G., Shen, B. & Li, Y. Tim-3: an activation marker and activation limiter of innate immune cells. Front. Immunol. 4, 449 [2013].
Article CAS PubMed PubMed Central Google Scholar
Sabatos, C. A. et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4, 1102 [2003].
Article CAS PubMed Google Scholar
Toshchakov, V. et al. TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages. Nat. Immunol. 3, 392 [2002].
Article CAS PubMed Google Scholar
Lee, J. et al. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 31, 3963–3974 [2011].
Article CAS PubMed PubMed Central Google Scholar
Anderson, A. C. et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318, 1141–1143 [2007].
Article CAS PubMed Google Scholar
Guha, M. & Mackman, N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277, 32124–32132 [2002].
Article CAS PubMed Google Scholar
Ma, C. J. et al. Cis association of galectin-9 with Tim-3 differentially regulates IL-12/IL-23 expressions in monocytes via TLR signaling. PloS ONE 8, e72488 [2013].
Article CAS PubMed PubMed Central Google Scholar
Makita, N. et al. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. Int. Immunol. 27, 131–141 [2014].
Article CAS PubMed Google Scholar
Zhang, Y. et al. Eosinophils reduce chronic inflammation in adipose tissue by secreting Th2 cytokines and promoting M2 macrophages polarization. Int. J. Endocrin. 2015, 1–5 [2015].
Lopez-Santalla, M. et al. AB0176 P38 MAPK phosphorylation as a rheumatoid arthritis biomarker. Ann. Rheum. Dis. 71, 647–647 [2013].
Article Google Scholar
Karin, M. & Delhase, M. The I kappa B kinase [IKK] and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol. 12, 85–98 [2000].
O'Sullivan, A. W., Wang, J. H. & Redmond, H. P. NF-κB and P38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. J. Surg. Res. 152, 46–53 [2009].
Article CAS PubMed Google Scholar
Liu, L. et al. Eosinophils attenuate arthritis by inducing M2 macrophage polarization via inhibiting the IκB/P38 MAPK signaling pathway. Biochem. B iophys. Res. Commun. 508, 894–901 [2019].
Article CAS Google Scholar
Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243–247 [2011].
Article CAS PubMed PubMed Central Google Scholar
Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535–549 [2013].
Article CAS PubMed PubMed Central Google Scholar
Schneider, C. et al. Frontline science: coincidental null mutation of Csf2rα in a colony of PI3Kγ−/− mice causes alveolar macrophage deficiency and fatal respiratory viral infection. J. Leukoc. Biol. 101, 367–376 [2017].
Article CAS PubMed Google Scholar
Nobs, S. P., Kayhan, M. & Kopf, M. GM-CSF intrinsically controls eosinophil accumulation in the setting of allergic airway inflammation. J. Allergy Clin. Immunol. 143, 1513–1524 [2019].
Schneider, C. et al. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 10, e1004053 [2014].
Article PubMed PubMed Central Google Scholar
Kopf, M. et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15–24 [1996].
Article CAS PubMed Google Scholar
Gaurav, R. & Agrawal, D. K. Clinical view on the importance of dendritic cells in asthma. Expert Rev. Clin. Immunol. 9, 899–919 [2013].
Article CAS PubMed PubMed Central Google Scholar
Chen, K. & Kolls, J. K. T Cell–mediated host immune defenses in the lung. Annu. Rev. Immunol. 31, 605–633 [2013].
Article CAS PubMed PubMed Central Google Scholar
Aderem, A. & Ulevitch, R. J. Toll-like receptors in the induction of the innate immune response. Nature 406, 782 [2000].
Article CAS PubMed Google Scholar
Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675 [2001].
Article CAS PubMed Google Scholar
Eder, W. et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. allergy Clin. Immunol. 113, 482–488 [2004].
Article CAS PubMed Google Scholar
Casanova, J.-L., Abel, L. & Quintana-Murci, L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447–491 [2011].
Article CAS PubMed Google Scholar
Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 17, 1–14 [2005].
Article CAS PubMed Google Scholar
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 [2006].
Article CAS PubMed Google Scholar
Peng, J. et al. SARM inhibits both TRIF‐and MyD88‐mediated AP‐1 activation. Eur. J. Immunol. 40, 1738–1747 [2010].
Article CAS PubMed Google Scholar
Mansell, A. et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148 [2006].
Article CAS PubMed Google Scholar
Han, C. et al. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 11, 734 [2010].
Article CAS PubMed Google Scholar
Palsson-McDermott, E. M. et al. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88–independent TLR4 pathway. Nat. Immunol. 10, 579 [2009].
Article CAS PubMed Google Scholar
Zakeri, A. & Yazdi, F. G. Toll-like receptor-mediated involvement of innate immune cells in asthma disease. Biochim. Biophys. Acta Gen. Subj. 1861, 3270–3277 [2017].
Article CAS PubMed Google Scholar
Matesic, D., Lenert, A. & Lenert, P. Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity. Curr. Allergy Asthma Rep. 12, 8–17 [2012].
Article CAS PubMed Google Scholar
Lefkowitz, R. J., Rajagopal, K. & Whalen, E. J. New roles for β-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell 24, 643–652 [2006].
Article CAS PubMed Google Scholar
Lefkowitz, R. J. & Whalen, E. J. β-arrestins: traffic cops of cell signaling. Curr. Opin. Cell Biol. 16, 162–168 [2004].
Article CAS PubMed Google Scholar
Walker, J. K. & DeFea, K. A. Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma. Curr. Opin. Pharmacol. 16, 142–147 [2014].
Article CAS PubMed Google Scholar
Shenoy, S. K. & Lefkowitz, R. J. Seven-transmembrane receptor signaling through β-arrestin. Sci. Signal. 2005, cm10 [2005].
Nichols, H. L. et al. β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway. Proc. Natl Acad. Sci. 109, 16660–16665 [2012].
Article PubMed PubMed Central Google Scholar
Walker, J. K. et al. β-Arrestin-2 regulates the development of allergic asthma. J. Clin. Investig. 112, 566–574 [2003].
Article CAS PubMed PubMed Central Google Scholar
Hollingsworth, J. W. et al. Both hematopoietic-derived and non–hematopoietic-derived β-arrestin–2 regulates murine allergic airway disease. Am. J. Respir. Cell Mol. Biol. 43, 269–275 [2010].
Article CAS PubMed Google Scholar
Shenoy, S. K. et al. β-Arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J. Biol. Chem. 281, 1261–1273 [2006].
Article CAS PubMed Google Scholar
Billington, C. K. & Penn, R. B. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir. Res. 4, 4 [2003].
Article Google Scholar
Kaulmann, A. & Bohn, T. Carotenoids, inflammation, and oxidative stress—implications of cellular signaling pathways and relation to chronic disease prevention. Nutr. Res. 34, 907–929 [2014].
Article CAS PubMed Google Scholar
Chen, X.-L. et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circul. Physiol. 290, H1862–H1870 [2006].
Article CAS Google Scholar
Kaplan, M. H. STAT signaling in inflammation. JAKSTAT. 2, e24198 [2013].
Braun, S. et al. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell Biol. 22, 5492–5505 [2002].
Article CAS PubMed PubMed Central Google Scholar
Wang, H. et al. RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res. 73, 3097–3108 [2013].
Article CAS PubMed Google Scholar
Plafker, K. S. et al. The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2. J. Biol. Chem. 285, 23064–23074 [2010].
Article CAS PubMed PubMed Central Google Scholar
Wang, X. J. et al. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs. Free Radic. Biol. Med. 70, 68–77 [2014].
Article CAS PubMed Google Scholar
Canning, P., Sorrell, F. J. & Bullock, A. N. Structural basis of Keap1 interactions with Nrf2. Free Radic. Biol. Med. 88, 101–107 [2015].
Article CAS PubMed PubMed Central Google Scholar
Kim, J.-H., Yu, S., Chen, J. D. & Kong, A.-N. The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains. Oncogene 32, 514 [2013].
Article CAS PubMed Google Scholar
Nioi, P., Nguyen, T., Sherratt, P. J. & Pickett, C. B. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol. Cell. Biol. 25, 10895–10906 [2005].
Article CAS PubMed PubMed Central Google Scholar
Li, W., Yu, S.-W. & Kong, A.-N. T. Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J. Biol. Chem. 281, 27251–27263 [2006].
Article CAS PubMed Google Scholar
Tong, K. I. et al. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 27, 7511–7521 [2007].
Article CAS PubMed PubMed Central Google Scholar
Cullinan, S. B. et al. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24, 8477–8486 [2004].
Article CAS PubMed PubMed Central Google Scholar
Hayes, J. D., McMahon, M., Chowdhry, S. & Dinkova-Kostova, A. T. Cancer chemoprevention mechanisms mediated through the Keap1–Nrf2 pathway. Antioxid. Redox Signal. 13, 1713–1748 [2010].
Article CAS PubMed Google Scholar
Ahmed, S. M. U. et al. Nrf2 signaling pathway: pivotal roles in inflammation. Biochim. Biophys. Acta 1863, 585–597 [2017].
Article CAS Google Scholar
Rada, P. et al. SCF/β-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell Biol. 31, 1121–1133 [2011].
Article CAS PubMed PubMed Central Google Scholar
Chowdhry, S. et al. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32, 3765 [2013].
Article CAS PubMed Google Scholar
Prestera, T. et al. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements [ARE]. Mol. Med. 1, 827–837 [1995].
Article CAS PubMed PubMed Central Google Scholar
Wunder, C. & Potter, R. F. The heme oxygenase system: its role in liver inflammation. Curr. Drug Targets Cardiovasc. Hematol. Disord. 3, 199–208 [2003].
Article CAS Google Scholar
Bauernfeind, F. G. et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787–791 [2009].
Article CAS PubMed Google Scholar
Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278 [2012].
Article CAS PubMed Google Scholar
Koziol-White, C. J. & Panettieri, R. A. Modulation of bronchomotor tone pathways in airway smooth muscle function and bronchomotor tone in asthma. Clin. Chest Med. 40, 51–57 [2019].
Article PubMed Google Scholar
Jude, J. A., Wylam, M. E., Walseth, T. F. & Kannan, M. S. Calcium signaling in airway smooth muscle. Proc. Am. Thorac. Soc. 5, 15–22 [2008].
Article CAS PubMed PubMed Central Google Scholar
Yoo, E. J. et al. Gα12 facilitates shortening in human airway smooth muscle by modulating phosphoinositide 3‐kinase‐mediated activation in a RhoA‐dependent manner. Br. J. Pharmacol. 174, 4383–4395 [2017].
Article CAS PubMed PubMed Central Google Scholar
Tliba, O. et al. IL‐13 enhances agonist‐evoked calcium signals and contractile responses in airway smooth muscle. Br. J. Pharmacol. 140, 1159–1162 [2003].
Article CAS PubMed PubMed Central Google Scholar
Chiba, Y. et al. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am. J. Respir. Cell Mol. Biol. 40, 159–167 [2009].
Article CAS PubMed Google Scholar
Young, H. W. et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5′ elements. Am. J. respiratory cell Mol. Biol. 37, 273–290 [2007].
Article CAS Google Scholar
Hoshino, M. et al. Increased expression of the human Ca2+-activated Cl− channel 1 [CaCC1] gene in the asthmatic airway. Am. J. Respir. Crit. Care Med. 165, 1132–1136 [2002].
Article PubMed Google Scholar
Alevy, Y. G. et al. IL-13–induced airway mucus production is attenuated by MAPK13 inhibition. J. Clin. Investig. 122, 4555–4568 [2012].
Article CAS PubMed PubMed Central Google Scholar
Park, K.-S. et al. SPDEF regulates goblet cell hyperplasia in the airway epithelium. J. Clin. Investig. 117, 978–988 [2007].
Article CAS PubMed PubMed Central Google Scholar
Ren, X. et al. FOXM1 promotes allergen-induced goblet cell metaplasia and pulmonary inflammation. Mol. Cell Biol. 33, 371–386 [2013].
Article CAS PubMed PubMed Central Google Scholar
Korfhagen, T. R. et al. SAM-pointed domain ETS factor mediates epithelial cell–intrinsic innate immune signaling during airway mucous metaplasia. Proc. Natl Acad. Sci. 109, 16630–16635 [2012].
Article PubMed PubMed Central Google Scholar
Le Cras, T. D. et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am. J. Physiol.Lung Cell. Mol. Physiol. 300, L414–L421 [2010].
Article CAS PubMed PubMed Central Google Scholar
Shao, M. X. & Nadel, J. A. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl Acad. Sci. 102, 767–772 [2005].
Article CAS PubMed PubMed Central Google Scholar
Perrais, M. et al. Induction of MUC2 and MUC5AC mucin by factors of the epidermal growth factor family is mediated by EGF-R/Ras/Raf/MAPK signaling cascade and Sp1. J. Biol. Chem. 277, 32258–32267[2002].
Erle, D. J. & Sheppard, D. The cell biology of asthma. J. Cell Biol. 205, 621–631 [2014].
Article CAS PubMed PubMed Central Google Scholar
Zhang, S. et al. Jagged1 is the major regulator of Notch‐dependent cell fate in proximal airways. Dev. Dyn. 242, 678–686 [2013].
Article CAS PubMed Google Scholar
Ou-Yang, H.-F., Wu, C.-G., Qu, S.-Y. & Li, Z.-K. Notch signaling downregulates MUC5AC expression in airway epithelial cells through Hes1-dependent mechanisms. Respiration 86, 341–346 [2013].
Article CAS PubMed Google Scholar
Nutku, E., Aizawa, H., Hudson, S. A. & Bochner, B. S. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101, 5014–5020 [2003].
Article CAS PubMed Google Scholar
Bochner, B. S. Siglec‐8 on human eosinophils and mast cells, and Siglec‐F on murine eosinophils, are functionally related inhibitory receptors. Clin. Exp. Allergy 39, 317–324 [2009].
Article CAS PubMed PubMed Central Google Scholar
Munitz, A. et al. The inhibitory receptor IRp60 [CD300a] suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107, 1996–2003 [2006].
Article CAS PubMed Google Scholar
Abbas, M. et al. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. Neurology 77, 1561–1564 [2011].
Article CAS PubMed Google Scholar
Neighbour, H. et al. Safety and efficacy of an oral CCR 3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo‐controlled clinical trial. Clin. Exp. Allergy 44, 508–516 [2014].
Article CAS PubMed Google Scholar
Wechsler, M. E. et al. Novel targeted therapies for eosinophilic disorders. J. Allergy Clin. Immunol. 130, 563–571 [2012].
Article CAS PubMed PubMed Central Google Scholar
Legrand, F. et al. The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 [EMR1]: a novel therapeutic target for eosinophilic disorders. J. Allergy Clin. Immunol. 133, 1439–1447 [2014]. e1438.
Article CAS PubMed PubMed Central Google Scholar
Pettipher, R. et al. Heightened response of eosinophilic asthmatic patients to the CRTH 2 antagonist OC 000459. Allergy 69, 1223–1232 [2014].
Article CAS PubMed Google Scholar
Krug, N. et al. Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. New Engl. J. Med. 372, 1987–1995 [2015].
Article PubMed Google Scholar
Ding, C., Li, J. & Zhang, X. Bertilimumab [Cambridge Antibody Technology Group]. Curr. Opin. Investig. Drugs 5, 1213–1218 [2004].
CAS PubMed Google Scholar
Ricketts, H. C. & Cowan, D. C. Asthma, obesity and targeted interventions: an update. Curr. Opin. Allergy Clin. Immunol. 19, 68–74 [2019].
Article PubMed Google Scholar
Detoraki, A. et al. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study. J. Asthma 53, 201–206 [2016].
Article CAS PubMed Google Scholar
Pelaia, G. et al. Targeted therapy in severe asthma today: focus on immunoglobulin E. Drug Des. Dev. Ther. 11, 1979 [2017].
Article CAS Google Scholar
Borish, L. C. et al. Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 160, 1816–1823 [1999].
Article CAS PubMed Google Scholar
Hart, T. et al. Preclinical efficacy and safety of pascolizumab [SB 240683]: a humanized anti‐interleukin‐4 antibody with therapeutic potential in asthma. Clin. Exp. Immunol. 130, 93–100 [2002].
Article CAS PubMed PubMed Central Google Scholar
Blanchard, C. et al. Inhibition of human interleukin‐13‐induced respiratory and oesophageal inflammation by anti‐human‐interleukin‐13 antibody [CAT‐354]. Clin. Exp. Allergy 35, 1096–1103 [2005].
Article CAS PubMed Google Scholar
Maselli, D. J., Keyt, H. & Rogers, L. Profile of lebrikizumab and its potential in the treatment of asthma. J. Asthma Allergy 8, 87 [2015].
Article CAS PubMed PubMed Central Google Scholar
Busse, W. W. et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti–IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am. J. Respir. Crit. Care Med. 188, 1294–1302 [2013].
Article CAS PubMed Google Scholar
Gauvreau, G. M. et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. New Engl. J. Med. 370, 2102–2110 [2014].
Article CAS PubMed Google Scholar
Agache, I. O. Endotype driven treatment of asthma. Curr. Treat. Options Allergy 1, 198–212 [2014].
Article Google Scholar
Canonica, G. W. et al. Therapeutic interventions in severe asthma. AWorld Allergy Organ. J. 9, 40 [2016].
Article Google Scholar
Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125 [2008].
Article CAS PubMed Google Scholar
Liu, X. et al. MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis. Biochem. Biophys.Res. Commun. 380, 177–182 [2009].
Article CAS PubMed Google Scholar
Taganov, K. D., Boldin, M. P., Chang, K.-J. & Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. 103, 12481–12486 [2006].
Article CAS PubMed PubMed Central Google Scholar
Liu, G. et al. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl Acad. Sci. 106, 15819–15824 [2009].
Article PubMed PubMed Central Google Scholar
Collison, A., Mattes, J., Plank, M. & Foster, P. S. Inhibition of house dust mite–induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 128, 160–167 [2011]. e164.
Article CAS PubMed Google Scholar
Tang, B. et al. Identification of MyD88 as a novel target of miR‐155, involved in negative regulation of Helicobacter pylori‐induced inflammation. FEBS Lett. 584, 1481–1486 [2010].
Article CAS PubMed Google Scholar
Zhang, Y., Zhong, M., Zhang, M. & Lv, K. Expression and clinical significance of miR-155 in peripheral blood CD4 [+]; T cells of patients with allergic asthma. Xi bao yu fen. zi mian yi xue za zhi Chin. J. Cell. Mol. Immunol. 28, 540–543 [2012].
CAS Google Scholar
O'Connell, R. M. et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. 104, 1604–1609 [2007].
Article CAS PubMed PubMed Central Google Scholar
Zech, A. & Ayata, K. MicroRNA-155 modulates P2R-signaling and Th2-priming of dendritic cells during allergic airway inflammation in mice. Pneumologie 70, V163 [2016].
Article Google Scholar
Lu, T. X., Munitz, A. & Rothenberg, M. E. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J. Immunol. 182, 4994–5002 [2009].
Article CAS PubMed Google Scholar
Sheedy, F. J. et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141 [2010].
Article CAS PubMed Google Scholar
Sawant, V. D. et al. Serum microRNA-21 as a biomarker for allergic inflammatory disease in children. MicroRNA 4, 36–40 [2015].
Article CAS PubMed Google Scholar
Veremeyko, T. et al. IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PloS ONE 8, e81774 [2013].
Article CAS PubMed PubMed Central Google Scholar
Tan, Z. et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 81, 829–834 [2007].
Article CAS PubMed PubMed Central Google Scholar
Nicodemus-Johnson, J. et al. Maternal asthma and microRNA regulation of soluble HLA-G in the airway. J. Allergy Clin. Immunol. 131, 1496–1503 [2013]. e1494.
Article CAS PubMed PubMed Central Google Scholar
Mattes, J. et al. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl Acad. Sci. 106, 18704–18709 [2009].
Article PubMed PubMed Central Google Scholar
Kumar, M., Mabalirajan, U., Agrawal, A. & Ghosh, B. Proinflammatory role of let-7 miRNAs in experimental asthma? J. Biol. Chem. 285, le19–le19 [2010].
Article CAS PubMed PubMed Central Google Scholar
Polikepahad, S. et al. Proinflammatory role for let-7 microRNAS in experimental asthma. J. Biol. Chem. 285, 30139–30149 [2010].
Article CAS PubMed PubMed Central Google Scholar
Kumar, M. et al. Let-7 microRNA–mediated regulation of IL-13 and allergic airway inflammation. J. Allergy Clin. Immunol. 128, 1077–1085 [2011]. e1010.
Article CAS PubMed Google Scholar
Mayoral, R. J. et al. MiR-221 influences effector functions and actin cytoskeleton in mast cells. PloS ONE 6, e26133 [2011].
Article CAS PubMed PubMed Central Google Scholar
Mayoral, R. J. et al. MicroRNA-221–222 regulate the cell cycle in mast cells. J. Immunol. 182, 433–445 [2009].
Article CAS PubMed Google Scholar
Li, J. J. et al. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. J. Allergy Clin. Immunol. 136, 462–473 [2015].
Article CAS PubMed Google Scholar
Di Valentin, E. et al. New asthma biomarkers: lessons from murine models of acute and chronic asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L185–L197 [2009].
Article CAS PubMed Google Scholar
Haj‐Salem, I. et al. MicroRNA‐19a enhances proliferation of bronchial epithelial cells by targeting TGFβR2 gene in severe asthma. Allergy 70, 212–219 [2015].
Article CAS PubMed Google Scholar
Liao, G., Panettieri, R. A. & Tang, D. D. Micro RNA‐203 negatively regulates c‐Abl, ERK 1/2 phosphorylation, and proliferation in smooth muscle cells. Physiol. Rep. 3, e12541 [2015].
Article CAS PubMed PubMed Central Google Scholar
Chiba, Y. et al. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am. J. Respir. Crit. Care Med. 180, 713–719 [2009].
Article CAS PubMed Google Scholar
Yamamoto, M. et al. Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge. BMC Genomics 13, 655 [2012].
Article CAS PubMed PubMed Central Google Scholar
McKenzie, A. N., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366–374 [2014].
Article CAS PubMed Google Scholar
Christianson, C. A. et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J. Allergy Clin. Immunol. 136, 59–68 [2015]. e14.
Article CAS PubMed PubMed Central Google Scholar
Singh, P. B. et al. MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation. J. Exp. Med. 214, 3627–3643 [2017].
Article CAS PubMed PubMed Central Google Scholar
McKenzie, A. et al. MicroRNA-155 protects group 2 innate lymphoid cells from apoptosis to promote type-2 immunity. Front. Immunol. 9, 2232 [2018].
Article CAS PubMed PubMed Central Google Scholar
Sharma, A. et al. Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. J. Appl. Physiol. 113, 459–464 [2012].
Article CAS PubMed Google Scholar
Kim, R. Y. et al. MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2. J. Allergy Clin. Immunol. 139, 519–532 [2017].
Article CAS PubMed Google Scholar
Dong, J. et al. MicroRNA networks in mouse lung organogenesis. PloS ONE 5, e10854 [2010].
Article CAS PubMed PubMed Central Google Scholar
Williams, A. E. et al. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev. Dyn. 236, 572–580 [2007].
Article CAS PubMed PubMed Central Google Scholar
Bhaskaran, M. et al. MicroRNA-127 modulates fetal lung development. Physiol. Genomics. 37, 268–278 [2009].
Article CAS PubMed PubMed Central Google Scholar
Lu, T. X. et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, Th2 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 187, 3362–3373 [2011].
Article CAS PubMed Google Scholar
Weidner, J., Malmhäll, C. & Rådinger, M. MicroRNAs in asthma pathogenesis-from mouse to man. J. Transl. Genet. Genom. 3, 2 [2019].
Google Scholar
Davis, J. S. et al. Circulating microRNAs and association with methacholine PC20 in the Childhood Asthma Management Program [CAMP] cohort. PloS ONE 12, e0180329 [2017].
Article CAS PubMed PubMed Central Google Scholar
Xie, Y. & Merkel, O. M. Pulmonary delivery of siRNA via polymeric vectors as therapies of asthma. Arch. der Pharmazie 348, 681–688 [2015].
Article CAS Google Scholar
Zafra, M. P. et al. Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice. PloS ONE 9, e91996 [2014].
Kho, A. T. et al. Circulating microRNAs and prediction of asthma exacerbation in childhood asthma. Respiratory Res. 19, 128 [2018].
Article CAS Google Scholar
Cheng, W. et al. MiR-143-3p controls TGF-β1-induced cell proliferation and extracellular matrix production in airway smooth muscle via negative regulation of the nuclear factor of activated T cells 1. Mol. Immunol. 78, 133–139 [2016].
Article CAS PubMed Google Scholar
Spurlock, C. F. III. et al. Expression and functions of long noncoding RNAs during human T helper cell differentiation. Nat. Commun. 6, 6932 [2015].
Article CAS PubMed Google Scholar
Huo, X. et al. Decreased epithelial and plasma miR‐181b‐5p expression associates with airway eosinophilic inflammation in asthma. Clin. Exp. Allergy 46, 1281–1290 [2016].
Article CAS PubMed Google Scholar
Maes, T. et al. Asthma inflammatory phenotypes show differential microRNA expression in sputum. J. Allergy Clin. Immunol. 137, 1433–1446 [2016].
Article CAS PubMed Google Scholar
Perry, M. M. et al. Role of non-coding RNAs in maintaining primary airway smooth muscle cells. Respir. Res. 15, 58 [2014].
Article CAS PubMed PubMed Central Google Scholar
Heffler, E. et al. MicroRNA profiling in asthma: potential biomarkers and therapeutic targets. Am. J. Respir. C ell Mol. Biol. 57, 642–650 [2017].
Article CAS Google Scholar